FDA Brief

FDA warning letters

A warning letter is FDA's formal notice that a company broke the law, usually found during an inspection. The company has 15 working days to reply. Letters that go unanswered lead to seizures, import bans or court orders.

15 letters match. Newest first.

  1. 7Tabz Retail, LLC

    FDA says 7Tabz Retail sells unapproved 7-OH drug products online with drug-like claims.

    High risk
  2. Royal Diamond Imports, Inc.

    FDA warned Royal Diamond Imports that its Roxy 7-OH kratom tablets are unapproved new drugs and its kratom drink mix contains an unsafe food additive.

    High risk
  3. Shaman Botanicals, LLC

    FDA warns Shaman Botanicals that its 7-OH chewable tablets are adulterated dietary supplements.

    High risk
  4. Relax Relief Rejuvenate Trading, LLC dba RRR Trading or EDP Kratom

    FDA says RRR Trading's EDP 7OH kratom extract shot is an adulterated supplement; its 7-OH ingredient lacks safety evidence.

    High risk
  5. Thang Botanicals, Inc. d/b/a 7ΩHMZ, 7-OHMZ, or 7OHMZ

    FDA says Thang Botanicals' 7OHMZ kratom shot, tablets, and gummies contain unsafe 7-OH and are adulterated.

    High risk
  6. Hydroxie, LLC

    FDA warned Hydroxie, LLC that its 7-OH tablets, strips, shots, and drink mix are unapproved drugs and an unsafe food additive.

    High risk
  7. My Smoke Wholesale

    My Smoke Wholesale's 777 Jackpot Alkaloids tablets are adulterated dietary supplements because 7-OH lacks adequate safety information.

    High risk
  8. Vape Hut, LLC d/b/a Vape Hut Kratom-CBD

    Family Smoking Prevention and Tobacco Control Act/Adulterated/Misbranded

  9. Shot of Joy LLC

    FDA warned Shot of Joy LLC that its kratom and kava products are unapproved new drugs marketed for opioid addiction and other conditions.

    High risk
  10. Sunshine Trading Company, Inc. dba Nova Tea and Nova Kratom

    FDA warned Nova Kratom that its kratom products are unapproved new drugs marketed to treat opioid addiction and withdrawal.

    High risk
  11. Herbsens Botanicals

    Herbsens Botanicals marketed kratom capsules and powders as unapproved drugs to treat opioid addiction and other conditions.

    High risk
  12. Klarity Kratom

    Klarity Kratom sold kratom products as unapproved drugs claiming they treat opioid addiction, FDA and FTC say.

    High risk
  13. Kratom Exchange

    FDA and FTC warned Kratom Exchange that it sells kratom as unapproved new drugs for opioid addiction and other conditions.

    High risk
  14. Omni Consumer Products LLC d/b/a YoKratom

    FDA and FTC warned YoKratom that its kratom products are unapproved new drugs marketed to treat opioid addiction.

    High risk
  15. Umbrella

    FDA warned Umbrella that its supplement and drug products, including Alpha Male Plus with hidden tadalafil, are unapproved and misbranded.

    High risk